Steven Cohen Enanta Pharmaceuticals Inc Transaction History
Point72 Asset Management, L.P.
- $51 Billion
- Q3 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 300,000 shares of ENTA stock, worth $3.62 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
300,000Holding current value
$3.62 Million% of portfolio
0.01%Shares
10 transactions
Others Institutions Holding ENTA
# of Institutions
128Shares Held
19.4MCall Options Held
290KPut Options Held
61.7K-
Farallon Capital Management LLC San Francisco, CA2.12MShares$25.6 Million0.11% of portfolio
-
Krensavage Asset Management, LLC New York, NY2.11MShares$25.5 Million10.78% of portfolio
-
Janus Henderson Group PLC London, X01.95MShares$23.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$23.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$22.3 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $250M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...